إعلان
إعلان
VNRX
VolitionRX Limited Common Stock
0.34
USDبرعاية
-0.02
-5.58%
٠٩ يناير, ١٥:٥٥ UTC -5
مغلق
بعد الإغلاق
0.33
-0.01
-1.79%
تقارير أرباح VNRX
النسبة الإيجابية المفاجئة
VNRX تفوق 24 من 40 آخر التقديرات.
60%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$780.47K
/-$0.04
التغير الضمني من Q3 25 (Revenue/ EPS)
+24.42%
/-20.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+306.50%
/-33.33%
VolitionRX Limited Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, VNRX reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -11.36% surprise. Revenue reached 627.28 ألف, compared to an expected 1.71 مليون, with a -63.41% difference. The market reacted with a -6.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of -0.04 USD, with revenue projected to reach 780.47 ألف USD, implying an نقصان of -20.00% EPS, and زيادة of 24.42% in Revenue from the last quarter.
الأسئلة الشائعة
What were VolitionRX Limited Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, VolitionRX Limited Common Stock reported EPS of -$0.05, missing estimates by -11.36%, and revenue of $627.28K, -63.41% below expectations.
How did the market react to VolitionRX Limited Common Stock's Q3 2025 earnings?
The stock price moved down -6.6%, changed from $0.35 before the earnings release to $0.33 the day after.
When is VolitionRX Limited Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for VolitionRX Limited Common Stock's next earnings report?
Based on 8
المحللين, VolitionRX Limited Common Stock is expected to report EPS of -$0.04 and revenue of $780.47K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان